Compare Dolby Laboratories, Inc. (DLB) vs Newmont Corporation (NEM) Price & Performance
Price performance (Past 24H)
Key statistics
Key statistics
Dolby Laboratories, Inc. vs Newmont Corporation — how do they compare? Dolby Laboratories, Inc. trades at $58.45 (market cap $5.47B), while Newmont Corporation trades at $118.02 (market cap $119.64B). The key difference: Newmont Corporation is far larger — about 21.9× Dolby Laboratories, Inc.'s market cap, and Dolby Laboratories, Inc. pays the higher dividend (2.47%). Which is the better fit depends on your goals — on Pluang, investors hold Dolby Laboratories, Inc. for 98 Days and Newmont Corporation for 58 Days on average.
| DLB | NEM | |
|---|---|---|
Market Cap | $5.47B | $119.64B |
Volume | 691,016 | 4,343,460 |
Sector | Technology | Basic Materials |
52-Week High | $70.09 | $135.14 |
52-Week Low | $48.51 | $78.63 |
Typical Hold Time | 98 Days | 58 Days |
Enterprise Value | $4.84B | $116.23B |
Dividend Yield | 2.47% | 0.92% |
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
Dolby Laboratories (DLB) trades at $58.35, down 0.19% with bearish technical signals despite strong profitability margins. The company maintains robust fundamentals with 87.61% gross margins and consistent earnings beats, though revenue has plateaued around $1.3B. Recent leadership transition to Marc Whitten and expanded Meta partnership for Dolby Atmos/Vision represent key developments. Technical indicators show resistance at $59 with support at $58.
DLB offers stable cash flow generation and dividend income but faces growth challenges with flat revenue. Analyst consensus targets $90.33 (55% upside) with 47% buy ratings, though near-term execution risks and licensing volatility warrant caution. The stock presents value for income investors but requires revenue acceleration for significant appreciation.
NEM trades at $115.55, down 0.72% on the day, with a bearish technical signal but strong fundamentals. Recent earnings beats and record free cash flow of $5.3B in H1 2026 highlight operational strength. The stock is supported by a 75.68% analyst buy rating and a consensus price target of $136.83, though it faces near-term resistance at $116.
The outlook remains positive given robust profitability and growth, but risks include gold price volatility and execution of per-share growth targets. Upside potential exists if the company continues to exceed earnings expectations and maintains its cash flow momentum.
Returns comparison
Trailing returns across standard periods
Returns comparison
Trailing returns across standard periods
Investor sentiment on Pluang
What Pluang investors did over the last 30 days
Investor sentiment on Pluang
What Pluang investors did over the last 30 days
No sentiment data available yet.
Top news
Latest headlines on both assets
Top news
Latest headlines on both assets
About Dolby Laboratories, Inc.
Dolby Laboratories Inc develops audio and surround sound for cinema, broadcast, home audio systems, in-car entertainment systems, DVD players, games, televisions, and personal computers. The company generates three fourths of its revenue from licensing its technology to consumer electronics manufacturers around the world. The rest of revenue comes from equipment sales to professional producers and audio engineering services.
Read more on DLB →About Newmont Corporation
Newmont Corp is primarily a gold producer with operations and/or assets in the United States, Canada, Mexico, Dominican Republic, Peru, Suriname, Argentina, Chile, Australia, and Ghana. It is also engaged in the production of copper, silver, lead and zinc. The company's operations are organized in five geographic regions: North America, South America, Australia, Africa and Nevada.
Read more on NEM →
